Medtronic’s
ICDs with Atrial Fibrillation Detection Win FDA Approval
Medtronic*has an**unced FDA
Approval of its latest single-chamber*implantable cardioverter defibrillators (ICDs) that feature the ability to detect
Atrial Fibrillation (AFib). The tech**logy allows for monitoring of recurrent, previously diag**sed AFib, as well as
Detection of undiag**sed and asymptomatic AFib.
Detection of AFib remains a challenge, as symptoms often appear seemingly randomly and last for a short time. Using external ECG monitors often misses events since these are typically worn for a relatively short time while AFib comes and goes as it likes. The frequency and length of detected AFib events are recorded and wirelessly shared
with the patient’s cardiologist.
The Visia AF MRI ICD is designed for safety inside an MRI machine, as long as precautions are taken, and works along
with Medtronic’s*Sprint Quattro Secure MRI SureScan DF4 leads.
The devices also feature SmartShock 2.0 tech**logy that reduces unnecessary shocks by being able to distinguish between dangerous and benign rhythms.
Flashback:*
Medtronic’s New ICDs with Atrial Fibrillation Detection Capabilities Win CE Mark in Europe…
Source:
Medtronic…
The post
Medtronic’s ICDs with Atrial Fibrillation Detection Win FDA Approval appeared first on
Medgadget.
